Clinical Trial Update: DAAOI-1 Treatment for Treatment-resistant Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of DAAOI-1 for treatment-resistant schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• DAAOI-1

Snippet

Sponsor: China Medical University Hospital | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED